Digitalis: The Insulin for Cancer?

alkylating agents, anticancer, ars cvrandi, barry groves, breast cancer res treat, cancer, cancer mortality, cancer res, cardiac, cardiac glycosides, carlos monteiro, cells, claudio baptista, coronary heart, coronary heart disease enigma, digitalis, disease, doctors and patients, estabilidade miocardica, et al, glycosides, heart, heart disease, heart protection study collaborative group, icp, infarct combat project, j. nat, johan haux, jon s. thorson, joseph m. langenhan, letter, med hypotheses, medical oncology, miguel lopez, mol pharmacol, mortality, new explanation strengthen, old remedy, oncol rep, p.  townsend letter, patients, physiol heart circ physiol, proc natl acad, prolongada sobrevida, quintiliano de mesquita, s.  ars cvrandi, s. provisional patent application ser, same therapeutic treatment, second opinions, shed light, sindromes coronarias agudas, study, thomas cowan, townsend letter, two heart disease theories, wayne martin, weidemann h. front biosci, wilhelm schoner